Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has swept the world in a pandemic. The disease (COVID-19) is characterized by acute respiratory distress, and there is an immediate need for any effective agent before the development of a vaccine. Coronavirus-19 disease (C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carlo Perricone, Elena Bartoloni, Roberto Gerli
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2020
Materias:
R
Acceso en línea:https://doaj.org/article/05c69d9bf924417f96de790ea9f6910c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has swept the world in a pandemic. The disease (COVID-19) is characterized by acute respiratory distress, and there is an immediate need for any effective agent before the development of a vaccine. Coronavirus-19 disease (COVID-19) is an infectious disease caused by SARS-CoV-2, a -coronavirus which causes pneumonia, requires intensive care unit hospitalization in about 10% of cases and can lead to a fatal outcome [1].